At AlluraMD, our wellness specialists will monitor the progress of your treatment and make any needed adjustments to ensure the best possible outcomes
Consistent Schedule: Whatever schedule you choose when you combine tesamorelin and retatrutide, consistency is key
Who Can Use These Medications The approval statuses of these drugs define their eligible patient populations
Her case was one of the first nine consolidated into MDL 3094
Patients in Dubai and Abu Dhabi can access these options after a consultation with our endocrinologist, with the standard support: free medication delivery (no markup), monthly follow-ups, body-composition tracking on every visit, and ongoing lifestyle coaching
Liraglutide Liraglutide (Victoza) was approved for use in T2D in 2009 by the EMA at doses of up to 1.8 mg once daily subcutaneous injection for people with T2D as monotherapy in those unable to take metformin or as add-on treatment to oral agents and/or insulin